NCT03628534View on ClinicalTrials.gov

SERF VT Ablation Early Feasibility Study (EFS)

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

June 30, 2021

Study Completion Date

July 31, 2022

Conditions
Ventricular TachycardiaArrythmiaHeart DiseasesCardiovascular Diseases
Interventions
DEVICE

Saline Enhanced Radiofrequency (SERF) ablation

Ablation of ventricular tachycardia with a saline-enhanced radiofrequency ablation catheter

Trial Locations (3)

37232

Vanderbilt Heart, Nashville

55905

Mayo Clinic, Rochester

60153

Loyola University Medical Center, Maywood

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Thermedical, Inc.

INDUSTRY

NCT03628534 - SERF VT Ablation Early Feasibility Study (EFS) | Biotech Hunter | Biotech Hunter